March 13, 2024 News by Margarida Maia, PhD Common MS therapies appear safe to use while breastfeeding Taking antibody-based medications for multiple sclerosis (MS) while breastfeeding does not appear to harm a child’s health or development during at least the first three years of life, according to a preliminary study of more than 180 babies. Children breastfed by mothers taking Tysabri (natalizumab), Ocrevus (ocrelizumab),…
April 7, 2023 News by Andrea Lobo, PhD Early treatment with Mavenclad, antibodies eased highly active MS Early treatment with Mavenclad (cladribine) or monoclonal antibodies is more likely to control symptoms in people with highly active multiple sclerosis (MS), a study in Argentina suggests. Highly active disease usually is considered when frequent relapses occur and there is an increasing burden of brain magnetic resonance imaging…
December 22, 2021 News by Marta Figueiredo, PhD 3 New COVID-19 Treatments Now Available to MS Patients in UK People with multiple sclerosis (MS) living in the U.K. are now eligible to receive one of three new treatments for COVID-19 that are meant to prevent serious disease in at-risk populations who tested positive for the virus. First available under this plan were Regeneron and Rocheās antibody-based therapy…
December 21, 2018 Columns by Ed Tobias Shots, Infusions, or Pills for Your MS? There are more than a dozen disease-modifying therapies available to treat MS. Some are shots, some are infusions, and some are pills. Some are more effective than others. The marketing intelligence company Spherix Global Insights regularly surveys which of these treatments are being used by neurologists and…
January 19, 2018 Columns by Ed Tobias Heavy-hitting MS Therapies Now Being Used Sooner for Some Patients I’m sitting in Florida and the start of spring training is only about six weeks from now, so please forgive a baseball analogy: The heavy-hitters of the MS-fighting treatments, the monoclonal antibodiesĀ (mAbs), are moving up in the lineup. Five treatments currently are in the mAbs class:Ā Ocrevus,…
November 9, 2017 Columns by Tamara Sellman The MS Alphabet: MRI, Myelin, mAbs, and Other ‘M’ Words Editorās note: Tamara Sellman continues her occasional series on the MS alphabet with this first of two columns about terms starting with the letter M. Symptoms of MS Memory problems Memory loss is a common complaint for people with MS. Even for those with no physical or…
October 27, 2016 News by Patricia Silva, PhD Selexis to Provide ImmuNext with Cell Lines for Research into Treatment for MS, Autoimmune Diseases SelexisĀ has entered into a commercial arrangementĀ with ImmuNext,Ā providing that company with access to research cell banks from itsĀ SURE technologyĀ Platform (a best-in-class cell line development technology). ImmuNext will use the cell banks in further developing its anti-CD40 ligand antibody, a potential therapeutic agentĀ for chronic autoimmune disorders such as multiple sclerosis…